| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder | 21 | 2020 | 118 | 3.390 |
Why?
|
| Vesico-Ureteral Reflux | 7 | 2017 | 11 | 3.250 |
Why?
|
| Urography | 6 | 2016 | 12 | 2.270 |
Why?
|
| Urethra | 7 | 2017 | 33 | 2.070 |
Why?
|
| Spinal Dysraphism | 6 | 2020 | 14 | 1.910 |
Why?
|
| Reconstructive Surgical Procedures | 9 | 2017 | 72 | 1.750 |
Why?
|
| Urologic Surgical Procedures | 12 | 2017 | 22 | 1.680 |
Why?
|
| Child | 36 | 2021 | 2141 | 1.650 |
Why?
|
| Urination | 7 | 2016 | 13 | 1.540 |
Why?
|
| Clinical Protocols | 3 | 2016 | 45 | 1.490 |
Why?
|
| Urologic Surgical Procedures, Male | 7 | 2017 | 15 | 1.460 |
Why?
|
| Child, Preschool | 29 | 2021 | 1087 | 1.430 |
Why?
|
| Urinary Bladder, Neurogenic | 5 | 2020 | 12 | 1.190 |
Why?
|
| Postoperative Complications | 10 | 2017 | 605 | 1.180 |
Why?
|
| Laparoscopy | 7 | 2021 | 143 | 1.150 |
Why?
|
| Regeneration | 11 | 2014 | 76 | 1.150 |
Why?
|
| Infant | 22 | 2020 | 954 | 1.080 |
Why?
|
| Male | 59 | 2021 | 12858 | 1.080 |
Why?
|
| Humans | 84 | 2021 | 26797 | 1.060 |
Why?
|
| Stem Cells | 5 | 2006 | 113 | 1.030 |
Why?
|
| Quality of Life | 6 | 2018 | 462 | 1.030 |
Why?
|
| Ureterocele | 2 | 2017 | 4 | 0.980 |
Why?
|
| Punctures | 2 | 2017 | 17 | 0.970 |
Why?
|
| Caregivers | 2 | 2017 | 110 | 0.960 |
Why?
|
| Tissue Engineering | 9 | 2014 | 152 | 0.940 |
Why?
|
| Ureteral Obstruction | 3 | 2008 | 12 | 0.930 |
Why?
|
| Decompression, Surgical | 2 | 2017 | 73 | 0.920 |
Why?
|
| Preoperative Care | 3 | 2015 | 76 | 0.850 |
Why?
|
| Cryptorchidism | 4 | 2021 | 10 | 0.840 |
Why?
|
| Penile Neoplasms | 6 | 2006 | 12 | 0.830 |
Why?
|
| Practice Guidelines as Topic | 4 | 2021 | 233 | 0.810 |
Why?
|
| Laser Therapy | 3 | 2017 | 30 | 0.810 |
Why?
|
| Circumcision, Male | 2 | 2013 | 2 | 0.780 |
Why?
|
| Foreskin | 2 | 2013 | 3 | 0.780 |
Why?
|
| Hydronephrosis | 3 | 2011 | 11 | 0.770 |
Why?
|
| Female | 45 | 2021 | 14437 | 0.750 |
Why?
|
| Bladder Exstrophy | 6 | 2009 | 7 | 0.730 |
Why?
|
| Retrospective Studies | 21 | 2017 | 2427 | 0.730 |
Why?
|
| Adolescent | 19 | 2020 | 2952 | 0.720 |
Why?
|
| Follow-Up Studies | 15 | 2017 | 980 | 0.690 |
Why?
|
| Aminolevulinic Acid | 9 | 2004 | 14 | 0.680 |
Why?
|
| Kidney Pelvis | 2 | 2010 | 5 | 0.680 |
Why?
|
| Disorders of Sex Development | 4 | 2017 | 13 | 0.660 |
Why?
|
| Urinary Incontinence | 7 | 2018 | 20 | 0.660 |
Why?
|
| Penis | 2 | 2017 | 16 | 0.650 |
Why?
|
| Ileum | 2 | 2010 | 23 | 0.650 |
Why?
|
| Treatment Outcome | 17 | 2017 | 2262 | 0.650 |
Why?
|
| Urologic Diseases | 3 | 2017 | 6 | 0.640 |
Why?
|
| Cystoscopy | 6 | 2017 | 16 | 0.630 |
Why?
|
| Penile Diseases | 2 | 2017 | 9 | 0.630 |
Why?
|
| Infant, Newborn | 14 | 2020 | 841 | 0.600 |
Why?
|
| Epispadias | 4 | 2011 | 4 | 0.590 |
Why?
|
| Cecostomy | 1 | 2017 | 4 | 0.590 |
Why?
|
| Ureteroscopy | 1 | 2017 | 5 | 0.590 |
Why?
|
| Lasers, Solid-State | 1 | 2017 | 5 | 0.580 |
Why?
|
| Fecal Incontinence | 1 | 2017 | 16 | 0.580 |
Why?
|
| Accidental Falls | 1 | 2017 | 31 | 0.570 |
Why?
|
| Urinary Bladder Neoplasms | 7 | 2005 | 159 | 0.570 |
Why?
|
| Cystography | 1 | 2016 | 1 | 0.560 |
Why?
|
| Patient Participation | 1 | 2017 | 52 | 0.560 |
Why?
|
| Urination Disorders | 1 | 2016 | 9 | 0.560 |
Why?
|
| Ergometry | 1 | 2016 | 7 | 0.550 |
Why?
|
| Cerebral Palsy | 1 | 2016 | 31 | 0.530 |
Why?
|
| Emotions | 1 | 2017 | 131 | 0.520 |
Why?
|
| Contrast Media | 2 | 2016 | 93 | 0.520 |
Why?
|
| Referral and Consultation | 2 | 2021 | 87 | 0.510 |
Why?
|
| Urinary Diversion | 2 | 2007 | 26 | 0.510 |
Why?
|
| Appendix | 2 | 2017 | 9 | 0.500 |
Why?
|
| Palpation | 1 | 2015 | 7 | 0.500 |
Why?
|
| Scrotum | 1 | 2015 | 8 | 0.500 |
Why?
|
| Wounds and Injuries | 1 | 2017 | 166 | 0.490 |
Why?
|
| Urothelium | 5 | 2014 | 35 | 0.490 |
Why?
|
| Blood Glucose | 1 | 2016 | 300 | 0.490 |
Why?
|
| Parenting | 1 | 2015 | 56 | 0.470 |
Why?
|
| Anxiety | 1 | 2015 | 136 | 0.450 |
Why?
|
| Stress, Psychological | 2 | 2017 | 209 | 0.450 |
Why?
|
| Phimosis | 1 | 2013 | 1 | 0.440 |
Why?
|
| Endoscopy | 4 | 2011 | 53 | 0.430 |
Why?
|
| Intestine, Small | 8 | 2014 | 66 | 0.430 |
Why?
|
| Laser Coagulation | 2 | 2002 | 13 | 0.420 |
Why?
|
| Gynecologic Surgical Procedures | 2 | 2017 | 33 | 0.410 |
Why?
|
| Parents | 4 | 2017 | 121 | 0.400 |
Why?
|
| Exercise | 1 | 2016 | 451 | 0.400 |
Why?
|
| Urinary Tract Infections | 2 | 2011 | 39 | 0.400 |
Why?
|
| Hypospadias | 2 | 2008 | 3 | 0.390 |
Why?
|
| Carcinoma, Transitional Cell | 5 | 2002 | 54 | 0.370 |
Why?
|
| Adult | 23 | 2020 | 7369 | 0.370 |
Why?
|
| Surgical Stomas | 2 | 2009 | 6 | 0.370 |
Why?
|
| Kidney | 2 | 2011 | 275 | 0.370 |
Why?
|
| Ureter | 1 | 2010 | 7 | 0.360 |
Why?
|
| Skin Neoplasms | 2 | 2009 | 128 | 0.350 |
Why?
|
| Nevus, Intradermal | 1 | 2009 | 1 | 0.350 |
Why?
|
| Photosensitizing Agents | 4 | 2002 | 33 | 0.350 |
Why?
|
| Protoporphyrins | 4 | 2004 | 11 | 0.330 |
Why?
|
| Stem Cell Transplantation | 3 | 2014 | 17 | 0.330 |
Why?
|
| Muscle, Smooth | 2 | 2006 | 40 | 0.330 |
Why?
|
| Neural Tube Defects | 1 | 2009 | 19 | 0.320 |
Why?
|
| Priapism | 1 | 2008 | 1 | 0.320 |
Why?
|
| Phenylephrine | 1 | 2008 | 13 | 0.320 |
Why?
|
| Ultrasonography | 4 | 2017 | 228 | 0.320 |
Why?
|
| Therapeutic Irrigation | 1 | 2008 | 19 | 0.320 |
Why?
|
| Urachal Cyst | 1 | 2008 | 1 | 0.320 |
Why?
|
| Urachus | 1 | 2008 | 1 | 0.320 |
Why?
|
| Vasoconstrictor Agents | 1 | 2008 | 34 | 0.320 |
Why?
|
| Prospective Studies | 7 | 2017 | 1216 | 0.310 |
Why?
|
| Robotic Surgical Procedures | 2 | 2021 | 43 | 0.310 |
Why?
|
| Testis | 2 | 2021 | 39 | 0.310 |
Why?
|
| Urinary Reservoirs, Continent | 2 | 2009 | 13 | 0.310 |
Why?
|
| Urogenital Surgical Procedures | 3 | 2016 | 9 | 0.300 |
Why?
|
| Biocompatible Materials | 4 | 2014 | 90 | 0.300 |
Why?
|
| Fellowships and Scholarships | 1 | 2008 | 38 | 0.300 |
Why?
|
| Risk Assessment | 6 | 2015 | 586 | 0.300 |
Why?
|
| Genital Diseases, Male | 2 | 2018 | 9 | 0.290 |
Why?
|
| Fluorescence | 8 | 2003 | 48 | 0.290 |
Why?
|
| Lymph Node Excision | 3 | 2006 | 94 | 0.290 |
Why?
|
| Body Mass Index | 1 | 2009 | 384 | 0.290 |
Why?
|
| Genitalia | 2 | 2017 | 8 | 0.280 |
Why?
|
| Incidence | 3 | 2017 | 546 | 0.280 |
Why?
|
| Cell Culture Techniques | 2 | 2005 | 115 | 0.280 |
Why?
|
| Abdomen | 1 | 2007 | 41 | 0.280 |
Why?
|
| Genitalia, Female | 2 | 2009 | 5 | 0.270 |
Why?
|
| Genitalia, Male | 2 | 2009 | 6 | 0.270 |
Why?
|
| Urinary Bladder Diseases | 1 | 2006 | 9 | 0.270 |
Why?
|
| Hernia, Inguinal | 1 | 2006 | 6 | 0.270 |
Why?
|
| Carcinoma | 2 | 2006 | 71 | 0.260 |
Why?
|
| Age Factors | 4 | 2017 | 714 | 0.260 |
Why?
|
| Diagnosis, Differential | 4 | 2015 | 368 | 0.260 |
Why?
|
| Cloaca | 3 | 2012 | 4 | 0.250 |
Why?
|
| Adaptation, Psychological | 2 | 2016 | 117 | 0.250 |
Why?
|
| Lymphatic Metastasis | 3 | 2006 | 119 | 0.250 |
Why?
|
| Cell Movement | 1 | 2006 | 352 | 0.240 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 496 | 0.230 |
Why?
|
| Sensitivity and Specificity | 6 | 2016 | 509 | 0.220 |
Why?
|
| Obesity | 1 | 2009 | 648 | 0.220 |
Why?
|
| Hyaluronic Acid | 3 | 2014 | 94 | 0.210 |
Why?
|
| Intestinal Mucosa | 6 | 2010 | 186 | 0.210 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2002 | 10 | 0.210 |
Why?
|
| Middle Aged | 13 | 2018 | 6807 | 0.200 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2002 | 33 | 0.200 |
Why?
|
| Robotics | 1 | 2002 | 42 | 0.200 |
Why?
|
| Urology | 3 | 2008 | 26 | 0.200 |
Why?
|
| Pediatrics | 2 | 2016 | 87 | 0.200 |
Why?
|
| Postoperative Period | 3 | 2017 | 66 | 0.190 |
Why?
|
| Adrenalectomy | 1 | 2021 | 13 | 0.190 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2021 | 15 | 0.190 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 748 | 0.180 |
Why?
|
| Nephrolithiasis | 1 | 2020 | 2 | 0.180 |
Why?
|
| Lymphoma, T-Cell | 1 | 2020 | 7 | 0.180 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2002 | 152 | 0.180 |
Why?
|
| Surveys and Questionnaires | 4 | 2018 | 916 | 0.170 |
Why?
|
| Telemedicine | 1 | 2002 | 135 | 0.170 |
Why?
|
| Models, Animal | 3 | 2006 | 129 | 0.170 |
Why?
|
| Acute Kidney Injury | 1 | 2020 | 73 | 0.170 |
Why?
|
| Animals | 15 | 2014 | 9945 | 0.170 |
Why?
|
| Anastomosis, Surgical | 2 | 2010 | 37 | 0.160 |
Why?
|
| Swine | 8 | 2014 | 220 | 0.160 |
Why?
|
| Men's Health | 1 | 2018 | 1 | 0.150 |
Why?
|
| Risk Factors | 2 | 2016 | 2009 | 0.150 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2018 | 6 | 0.150 |
Why?
|
| Prognosis | 5 | 2017 | 759 | 0.150 |
Why?
|
| Young Adult | 6 | 2020 | 2576 | 0.150 |
Why?
|
| Germany | 2 | 2011 | 24 | 0.150 |
Why?
|
| Oklahoma | 2 | 2021 | 970 | 0.150 |
Why?
|
| Case-Control Studies | 2 | 2017 | 701 | 0.150 |
Why?
|
| Neurogenic Bowel | 1 | 2017 | 4 | 0.150 |
Why?
|
| Urethral Diseases | 2 | 2010 | 6 | 0.150 |
Why?
|
| Emotional Adjustment | 1 | 2017 | 1 | 0.150 |
Why?
|
| Rupture | 1 | 2017 | 11 | 0.150 |
Why?
|
| Constipation | 1 | 2017 | 21 | 0.150 |
Why?
|
| Catheterization | 1 | 2017 | 50 | 0.140 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 2017 | 4 | 0.140 |
Why?
|
| Health Personnel | 1 | 2018 | 91 | 0.140 |
Why?
|
| Forecasting | 1 | 2017 | 71 | 0.140 |
Why?
|
| Clinical Decision-Making | 1 | 2017 | 61 | 0.140 |
Why?
|
| Operative Time | 1 | 2017 | 40 | 0.140 |
Why?
|
| Patient Safety | 1 | 2017 | 36 | 0.140 |
Why?
|
| Genital Diseases, Female | 1 | 2016 | 6 | 0.140 |
Why?
|
| Pregnancy | 5 | 2012 | 1127 | 0.140 |
Why?
|
| Tissue Scaffolds | 2 | 2014 | 88 | 0.140 |
Why?
|
| Transitional Care | 1 | 2016 | 3 | 0.140 |
Why?
|
| Glucose Tolerance Test | 1 | 2016 | 57 | 0.140 |
Why?
|
| Societies, Medical | 1 | 2016 | 89 | 0.140 |
Why?
|
| Treatment Failure | 3 | 2010 | 68 | 0.130 |
Why?
|
| Parent-Child Relations | 1 | 2016 | 70 | 0.130 |
Why?
|
| Rats | 6 | 2014 | 1544 | 0.130 |
Why?
|
| Adiposity | 1 | 2016 | 87 | 0.130 |
Why?
|
| Nephrectomy | 3 | 2011 | 48 | 0.130 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 909 | 0.130 |
Why?
|
| Disabled Children | 1 | 2015 | 12 | 0.120 |
Why?
|
| Reoperation | 2 | 2007 | 144 | 0.120 |
Why?
|
| Depressive Disorder | 1 | 2015 | 53 | 0.120 |
Why?
|
| Guided Tissue Regeneration | 1 | 2014 | 4 | 0.120 |
Why?
|
| Anxiety Disorders | 1 | 2015 | 59 | 0.120 |
Why?
|
| Insulin Resistance | 1 | 2016 | 165 | 0.120 |
Why?
|
| Re-Epithelialization | 1 | 2014 | 5 | 0.120 |
Why?
|
| Biopsy | 4 | 2003 | 199 | 0.120 |
Why?
|
| Mucous Membrane | 1 | 2014 | 26 | 0.120 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2014 | 27 | 0.120 |
Why?
|
| Cystectomy | 3 | 2014 | 103 | 0.120 |
Why?
|
| Hyaluronan Receptors | 1 | 2014 | 29 | 0.120 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2015 | 68 | 0.120 |
Why?
|
| Time Factors | 4 | 2011 | 1565 | 0.120 |
Why?
|
| Mental Health | 1 | 2015 | 96 | 0.120 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 109 | 0.120 |
Why?
|
| Sex Factors | 1 | 2015 | 444 | 0.110 |
Why?
|
| Equipment Design | 3 | 2003 | 211 | 0.110 |
Why?
|
| Depression | 1 | 2015 | 210 | 0.110 |
Why?
|
| Urinary Catheterization | 2 | 2009 | 15 | 0.100 |
Why?
|
| Severity of Illness Index | 3 | 2008 | 447 | 0.100 |
Why?
|
| Probability | 2 | 2009 | 75 | 0.100 |
Why?
|
| RNA, Messenger | 1 | 2014 | 645 | 0.100 |
Why?
|
| Bedding and Linens | 1 | 2012 | 2 | 0.100 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2012 | 34 | 0.100 |
Why?
|
| Heating | 1 | 2012 | 6 | 0.100 |
Why?
|
| Hypothermia | 1 | 2012 | 6 | 0.100 |
Why?
|
| Wilms Tumor | 1 | 2011 | 7 | 0.100 |
Why?
|
| Anesthesia, General | 1 | 2012 | 30 | 0.100 |
Why?
|
| Testicular Neoplasms | 1 | 2011 | 15 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2002 | 309 | 0.100 |
Why?
|
| Combined Modality Therapy | 2 | 2011 | 290 | 0.100 |
Why?
|
| North America | 1 | 2011 | 39 | 0.100 |
Why?
|
| Aged | 8 | 2006 | 5158 | 0.090 |
Why?
|
| Gender Identity | 2 | 2015 | 20 | 0.090 |
Why?
|
| Surgical Wound Infection | 1 | 2011 | 104 | 0.090 |
Why?
|
| Prenatal Diagnosis | 1 | 2010 | 17 | 0.090 |
Why?
|
| Early Diagnosis | 1 | 2010 | 32 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2013 | 968 | 0.090 |
Why?
|
| Polyglycolic Acid | 1 | 2010 | 36 | 0.090 |
Why?
|
| Kidney Neoplasms | 1 | 2011 | 101 | 0.090 |
Why?
|
| Adjuvants, Immunologic | 1 | 2010 | 62 | 0.090 |
Why?
|
| Graft Survival | 1 | 2010 | 27 | 0.090 |
Why?
|
| Graft Rejection | 1 | 2010 | 33 | 0.090 |
Why?
|
| Radioisotope Renography | 1 | 2010 | 29 | 0.090 |
Why?
|
| Colonic Pouches | 1 | 2010 | 1 | 0.090 |
Why?
|
| Lactic Acid | 1 | 2010 | 89 | 0.090 |
Why?
|
| Postoperative Care | 1 | 2010 | 67 | 0.090 |
Why?
|
| Aged, 80 and over | 6 | 2006 | 1925 | 0.090 |
Why?
|
| Intraoperative Period | 1 | 2009 | 21 | 0.090 |
Why?
|
| Cystitis | 1 | 2009 | 11 | 0.090 |
Why?
|
| Hydroxyprostaglandin Dehydrogenases | 1 | 2009 | 16 | 0.090 |
Why?
|
| 3-Hydroxysteroid Dehydrogenases | 1 | 2009 | 17 | 0.090 |
Why?
|
| Remote Consultation | 1 | 2009 | 3 | 0.080 |
Why?
|
| Leukocytes | 1 | 2009 | 68 | 0.080 |
Why?
|
| Mosaicism | 1 | 2009 | 12 | 0.080 |
Why?
|
| Electronic Mail | 1 | 2009 | 10 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2014 | 545 | 0.080 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2009 | 16 | 0.080 |
Why?
|
| Genetic Counseling | 1 | 2009 | 14 | 0.080 |
Why?
|
| Abnormalities, Multiple | 2 | 2009 | 34 | 0.080 |
Why?
|
| Second-Look Surgery | 1 | 2008 | 4 | 0.080 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2008 | 4 | 0.080 |
Why?
|
| Kidney Calculi | 1 | 2008 | 6 | 0.080 |
Why?
|
| Premedication | 1 | 2008 | 5 | 0.080 |
Why?
|
| Dihydrotestosterone | 1 | 2008 | 9 | 0.080 |
Why?
|
| Tissue Culture Techniques | 2 | 2005 | 30 | 0.080 |
Why?
|
| Phosphoproteins | 1 | 2008 | 115 | 0.080 |
Why?
|
| Androgens | 1 | 2008 | 47 | 0.080 |
Why?
|
| Ischemia | 1 | 2008 | 83 | 0.080 |
Why?
|
| Sexual Behavior | 1 | 2008 | 87 | 0.080 |
Why?
|
| False Positive Reactions | 3 | 2002 | 30 | 0.070 |
Why?
|
| Prune Belly Syndrome | 1 | 2007 | 1 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2008 | 204 | 0.070 |
Why?
|
| Pain, Postoperative | 1 | 2007 | 59 | 0.070 |
Why?
|
| Manikins | 1 | 2006 | 7 | 0.070 |
Why?
|
| Cell Line | 2 | 2005 | 672 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2008 | 394 | 0.070 |
Why?
|
| Polyps | 1 | 2005 | 2 | 0.070 |
Why?
|
| Carcinoma in Situ | 2 | 2002 | 44 | 0.060 |
Why?
|
| Infant, Premature, Diseases | 1 | 2006 | 37 | 0.060 |
Why?
|
| Lymph Nodes | 1 | 2006 | 95 | 0.060 |
Why?
|
| Stromal Cells | 1 | 2005 | 60 | 0.060 |
Why?
|
| Bone Marrow Cells | 1 | 2005 | 79 | 0.060 |
Why?
|
| Rats, Nude | 1 | 2005 | 5 | 0.060 |
Why?
|
| Comorbidity | 1 | 2006 | 252 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2008 | 466 | 0.060 |
Why?
|
| Infant, Premature | 1 | 2006 | 133 | 0.060 |
Why?
|
| Administration, Intravesical | 2 | 2001 | 16 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2005 | 387 | 0.060 |
Why?
|
| Prolapse | 1 | 2003 | 3 | 0.060 |
Why?
|
| Living Donors | 1 | 2003 | 3 | 0.060 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2006 | 89 | 0.060 |
Why?
|
| Adrenal Hyperplasia, Congenital | 2 | 2015 | 11 | 0.060 |
Why?
|
| Pelvic Bones | 1 | 2003 | 14 | 0.060 |
Why?
|
| Osteotomy | 1 | 2003 | 23 | 0.060 |
Why?
|
| Skin Diseases, Parasitic | 1 | 2003 | 1 | 0.060 |
Why?
|
| Skin Diseases, Papulosquamous | 1 | 2003 | 1 | 0.060 |
Why?
|
| Dermatomycoses | 1 | 2003 | 3 | 0.060 |
Why?
|
| Photochemotherapy | 1 | 2004 | 39 | 0.060 |
Why?
|
| Neodymium | 1 | 2003 | 1 | 0.060 |
Why?
|
| Condylomata Acuminata | 1 | 2003 | 4 | 0.060 |
Why?
|
| Yttrium | 1 | 2003 | 2 | 0.060 |
Why?
|
| Aluminum | 1 | 2003 | 6 | 0.050 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2003 | 16 | 0.050 |
Why?
|
| Kidney Transplantation | 1 | 2003 | 43 | 0.050 |
Why?
|
| Dogs | 3 | 2010 | 504 | 0.050 |
Why?
|
| Telecommunications | 1 | 2002 | 4 | 0.050 |
Why?
|
| Baltimore | 1 | 2002 | 12 | 0.050 |
Why?
|
| Diagnostic Techniques, Surgical | 1 | 2002 | 2 | 0.050 |
Why?
|
| Lasers | 1 | 2002 | 67 | 0.050 |
Why?
|
| Precancerous Conditions | 1 | 2002 | 32 | 0.050 |
Why?
|
| Papillomaviridae | 1 | 2002 | 85 | 0.050 |
Why?
|
| Medical Overuse | 1 | 2021 | 3 | 0.050 |
Why?
|
| Datasets as Topic | 1 | 2021 | 21 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2018 | 857 | 0.050 |
Why?
|
| Diagnostic Errors | 1 | 2021 | 33 | 0.050 |
Why?
|
| Congenital Abnormalities | 1 | 2021 | 16 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 453 | 0.050 |
Why?
|
| Quality of Health Care | 1 | 2021 | 77 | 0.050 |
Why?
|
| Guideline Adherence | 1 | 2021 | 91 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2004 | 270 | 0.050 |
Why?
|
| Urodynamics | 1 | 2020 | 5 | 0.040 |
Why?
|
| Coculture Techniques | 2 | 2013 | 53 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2001 | 245 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2002 | 376 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2004 | 1392 | 0.040 |
Why?
|
| Humidity | 1 | 2017 | 7 | 0.040 |
Why?
|
| Intraoperative Complications | 1 | 2017 | 47 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 249 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 400 | 0.030 |
Why?
|
| 46, XX Disorders of Sex Development | 1 | 2015 | 1 | 0.030 |
Why?
|
| Gonadal Dysgenesis, 46,XY | 1 | 2015 | 2 | 0.030 |
Why?
|
| Turner Syndrome | 1 | 2015 | 7 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2016 | 159 | 0.030 |
Why?
|
| Decision Making | 1 | 2017 | 169 | 0.030 |
Why?
|
| Karyotyping | 1 | 2015 | 24 | 0.030 |
Why?
|
| Recurrence | 2 | 2008 | 315 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2006 | 456 | 0.030 |
Why?
|
| Nanotechnology | 1 | 2014 | 67 | 0.030 |
Why?
|
| Mass Screening | 1 | 2015 | 141 | 0.030 |
Why?
|
| Algorithms | 1 | 2016 | 419 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 439 | 0.030 |
Why?
|
| Hospitals, University | 1 | 2012 | 26 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2012 | 43 | 0.030 |
Why?
|
| Body Temperature Regulation | 1 | 2012 | 12 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2011 | 12 | 0.020 |
Why?
|
| Body Temperature | 1 | 2012 | 30 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2010 | 11 | 0.020 |
Why?
|
| Amniotic Fluid | 1 | 2010 | 5 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2010 | 11 | 0.020 |
Why?
|
| Duodenum | 1 | 2010 | 15 | 0.020 |
Why?
|
| Fetal Diseases | 1 | 2010 | 18 | 0.020 |
Why?
|
| Aldo-Keto Reductase Family 1 Member C3 | 1 | 2009 | 21 | 0.020 |
Why?
|
| Puberty | 1 | 2009 | 13 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2010 | 53 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2009 | 55 | 0.020 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2010 | 18 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2010 | 111 | 0.020 |
Why?
|
| Cystostomy | 1 | 2009 | 1 | 0.020 |
Why?
|
| Amniocentesis | 1 | 2009 | 3 | 0.020 |
Why?
|
| Stillbirth | 1 | 2009 | 14 | 0.020 |
Why?
|
| Fibrosis | 1 | 2009 | 115 | 0.020 |
Why?
|
| Polytetrafluoroethylene | 1 | 2009 | 8 | 0.020 |
Why?
|
| Medical Records | 1 | 2009 | 49 | 0.020 |
Why?
|
| Dextrans | 1 | 2009 | 22 | 0.020 |
Why?
|
| Inflammation | 1 | 2013 | 601 | 0.020 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2008 | 17 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2008 | 18 | 0.020 |
Why?
|
| Gels | 1 | 2008 | 26 | 0.020 |
Why?
|
| Neutrophils | 1 | 2009 | 177 | 0.020 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2009 | 70 | 0.020 |
Why?
|
| Reference Values | 1 | 2008 | 197 | 0.020 |
Why?
|
| Collagen | 1 | 2009 | 147 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2011 | 340 | 0.020 |
Why?
|
| Oligohydramnios | 1 | 2007 | 2 | 0.020 |
Why?
|
| Fluid Therapy | 1 | 2007 | 14 | 0.020 |
Why?
|
| Cytokines | 1 | 2009 | 440 | 0.020 |
Why?
|
| Inguinal Canal | 1 | 2006 | 3 | 0.020 |
Why?
|
| Phenotype | 1 | 2009 | 664 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2010 | 273 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 357 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2006 | 56 | 0.020 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2006 | 16 | 0.020 |
Why?
|
| Calcimycin | 1 | 2005 | 11 | 0.020 |
Why?
|
| Ionophores | 1 | 2005 | 6 | 0.020 |
Why?
|
| Femur | 1 | 2005 | 21 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2006 | 123 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2005 | 38 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2005 | 161 | 0.010 |
Why?
|
| Administration, Topical | 1 | 2003 | 28 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2005 | 766 | 0.010 |
Why?
|
| Skin | 1 | 2003 | 140 | 0.010 |
Why?
|
| Random Allocation | 1 | 2001 | 148 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 801 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 2001 | 24 | 0.010 |
Why?
|